ArticleThe Journal of clinical investigation2022

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.

Laura A Sena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.